APA (7th ed.) Citation

Berraondo, P., Melero, I., Sanmamed, M. F., Andrea, C. E. D., Campos, M., Eguren-Santamaria, I., . . . Álvarez-Gigli, L. (2024, September). MHC class I and II-deficient humanized mice are suitable tools to test the long-term antitumor efficacy of immune checkpoint inhibitors and T-cell engagers. Journal for ImmunoTherapy of Cancer.

Chicago Style (17th ed.) Citation

Berraondo, Pedro, et al. "MHC Class I and II-deficient Humanized Mice Are Suitable Tools to Test the Long-term Antitumor Efficacy of Immune Checkpoint Inhibitors and T-cell Engagers." Journal for ImmunoTherapy of Cancer Sep. 2024.

MLA (9th ed.) Citation

Berraondo, Pedro, et al. "MHC Class I and II-deficient Humanized Mice Are Suitable Tools to Test the Long-term Antitumor Efficacy of Immune Checkpoint Inhibitors and T-cell Engagers." Journal for ImmunoTherapy of Cancer, Sep. 2024.